Showing results (191-200 of 224) with videos related to
Sort By:
Pageof 23
Medical Oncology (Northwood, London, England)|May 20, 2019
Bone marrow examination in patients with Ewing sarcoma/peripheral primitive neuroectodermal tumor without metastasis based on 18F-fluorodeoxyglucose positron emission tomography/computed tomographyChiaki Inagaki, Tatsunori Shimoi, Hitomi Sumiyoshi Okuma, et al.Cancers|June 27, 2024
Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and ParagangliomaMasaki Uchihara, Akiyo Tanabe, Yuki Kojima, et al.Cancer Chemotherapy and Pharmacology|April 28, 2017
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in JapaneseYuko Tanabe, Chikako Shimizu, Akinobu Hamada, et al.The Lancet. Oncology|October 18, 2017
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody-drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation studyToshihiko Doi, Kohei Shitara, Yoichi Naito, et al.EJNMMI Research|April 9, 2015
(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patientsHiroaki Kurihara, Akinobu Hamada, Masayuki Yoshida, et al.International Journal of Clinical Oncology|December 6, 2018
Palbociclib in combination with letrozole in patients with estrogen receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: PALOMA-2 subgroup analysis of Japanese patientsHirofumi Mukai, Chikako Shimizu, Norikazu Masuda, et al.Translational Oncology|August 6, 2019
Gene Alterations in Triple-Negative Breast Cancer Patients in a Phase I/II Study of Eribulin and Olaparib Combination TherapyAkihiko Shimomura, Kan Yonemori, Masayuki Yoshida, et al.Cancer Science|July 1, 2017
Phase 1 dose-escalation study of single-agent veliparib in Japanese patients with advanced solid tumorsTadaaki Nishikawa, Koji Matsumoto, Kenji Tamura, et al.Journal of Global Oncology|May 25, 2019
Palbociclib Plus Letrozole as First-Line Therapy in Postmenopausal Asian Women With Metastatic Breast Cancer: Results From the Phase III, Randomized PALOMA-2 StudySeock-Ah Im, Hirofumi Mukai, In Hae Park, et al.Oncotarget|February 22, 2018
Gene aberration profile of tumors of adolescent and young adult femalesYasuyuki Kanke, Akihiko Shimomura, Motonobu Saito, et al.Pageof 23